Ghrelin (human)
(Synonyms: 来诺瑞林) 目录号 : GC16346
人类胃泌素（Ghrelin）是从人类和大鼠肠道中分离出来的内源性生长激素分泌素受体（GHS-R）的配体，并对弧形神经元活动产生影响，其亲和力比GHSR拮抗剂（D-Lys3）-GHRP-6强得多（IC50为0.3×10-9M，0.9×10-6M）。
Cas No.:258279-04-8
Sample solution is provided at 25 µL, 10mM.
Ghrelin (human) was isolated from the gut of both human and rat as the endogenous ligand of the growth hormone secretagogue receptor (GHS-R), and has an effection on the activity of arcute neurones with a much stronger affinity (IC50, 0.3×10-9M) than GHSR antagonist (D-Lys3)-GHRP-6 (IC50, 0.9×10-6M) [1]. The highest levels of ghrelin are secreted from the X/A - like cells of the oxyntic glands located in the gastric fundus, with lower levels widely distributed throughout the body [2]. Ghrelin is secreted direct into the local gastric circulation and transported to the brain directly, requiring it to either cross the blood-brain barrier via a saturated transport system or via the blood stream to enter areas of the brain that are not protected by the blood-brain barrier [3]. Ghrelin modulates the hypothalamic arcuate nucleus, in an indirect manner, via activation of the vagus nerve and brain stem nuclei [4]. Ghrelin has a homeostatic role that encompasses multiple areas of the body, with actions that include downregulation of brown adipose tissue thermogenesis [5-7], modulation of non-hypothalamic brain regions producing an increased taste sensation [7] and stimulation of gastric emptying and motility [8]. The actions of ghrelin may contribute to the development of T2DM and obesity [9].
Differentiating visceral adipocytes were exposed to increasing concentrations of acylated (human) and desacyl ghrelin (0.1-1000 pmol l-1) for 48 h, and induced a significant increase in PPARG and SREBF1 transcript levels, the proportion of cells positive for lipid droplets was markedly increased in the presence of both ghrelin forms, compared with the cells in the differentiation medium without ghrelin [10].
References:
[1]. Traebert M, Riediger T, Whitebread S, et al. Ghrelin acts on leptin‐responsive neurones in the rat arcuate nucleus[J]. Journal of neuroendocrinology, 2002, 14(7): 580-586.
[2]. Dixit V D, Schaffer E M, Pyle R S, et al. Ghrelin inhibits leptin-and activation-induced proinflammatory cytokine expression by human monocytes and T cells[J]. The Journal of clinical investigation, 2004, 114(1): 57-66.
[3]. Angelidis G, Valotassiou V, Georgoulias P. Current and potential roles of ghrelin in clinical practice[J]. Journal of endocrinological investigation, 2010, 33(11): 823-838.
[4]. Date Y, Murakami N, Toshinai K, et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats[J]. Gastroenterology, 2002, 123(4): 1120-1128.
[5]. Tsubone T, Masaki T, Katsuragi I, et al. Ghrelin regulates adiposity in white adipose tissue and UCP1 mRNA expression in brown adipose tissue in mice[J]. Regulatory peptides, 2005, 130(1-2): 97-103.
[6]. Whittle A J, LÓpez M, Vidal-Puig A. Using brown adipose tissue to treat obesity-the central issue[J]. Trends in molecular medicine, 2011, 17(8): 405-411.
[7]. Mano-Otagiri A, Iwasaki-Sekino A, Nemoto T, et al. Genetic suppression of ghrelin receptors activates brown adipocyte function and decreases fat storage in rats[J]. Regulatory peptides, 2010, 160(1-3): 81-90.
[8]. Masuda Y, Tanaka T, Inomata N, et al. Ghrelin stimulates gastric acid secretion and motility in rats[J]. Biochemical and biophysical research communications, 2000, 276(3): 905-908.
[9]. MÜller T D, Nogueiras R, Andermann M L, et al. Ghrelin[J]. Molecular metabolism, 2015, 4(6): 437-460.
[10]. RodrÍguez A, GÓmez-Ambrosi J, CatalÁn V, et al. Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes[J]. International journal of obesity, 2009, 33(5): 541-552.
人类胃泌素（Ghrelin）是从人类和大鼠肠道中分离出来的内源性生长激素分泌素受体（GHS-R）的配体,并对弧形神经元活动产生影响,其亲和力比GHSR拮抗剂（D-Lys3）-GHRP-6强得多（IC50为0.3×10-9M,0.9×10-6M）[1]。胃泌素最高水平的分泌源是位于胃底部酸性腺中的X/A-类细胞,较低水平的分布广泛在全身[2]。胃泌素直接分泌到局部胃循环中,并直接输送到大脑,要求它要么通过饱和的转运系统穿越血脑屏障,要么通过血流进入未受血脑屏障保护的脑部区域[3]。胃泌素通过激活迷走神经和脑干核间接地调节下丘脑弧形核[4]。胃泌素具有涵盖身体多个区域的稳态作用,其作用包括下调棕色脂肪组织的热发生[5-7]、调节非下丘脑的脑区产生增加的味觉感觉[7]以及促进胃排空和运动[8]。胃泌素的作用可能有助于2型糖尿病和肥胖的发展[9]。
将分化的内脏脂肪细胞暴露于逐渐增加的酰化（人）和去酰化胃泌素（0.1-1000 pmol / L）浓度中,持续48小时,结果显示与没有酰化胃泌素的分化培养基相比,PPARG和SREBF1转录水平明显增加,呈现出更多的含脂滴细胞比例增加。[10]
| Cell experiment [1]: | |
|
Cell lines |
Human stromovascular fraction cells (SVFCs) |
|
Preparation Method |
Adipocyte differentiation was initiated when cells reached ∼80-90% confluence. Cells were stimulated with differentiation medium I (adipocyte medium supplemented with 10% NCS, 0.5 mmol l-1 3-isobutyl-1-methylxanthine, 0.1 µmol l-1 dexamethasone and 10 µg ml-1 insulin) for 2 days. Furthermore, the cells were then switched to differentiation medium II (adipocyte medium supplemented with 10% NCS and 10 µg ml-1 insulin) for another 6 days and media were changed every 2 days. Adipocytes were 70-75% differentiated (as determined by morphology) in the eighth day of differentiation. They were incubated for 2 h in a serum-free adipocyte medium and, then, stimulated with different concentrations of acylated Ghrelin (human) or with desacyl ghrelin (0.1, 1, 10, 100 and 1000 pmol l-1) for 48 h. One sample per experiment was used for obtaining control responses in the presence of a solvent. |
|
Reaction Conditions |
0.1, 1, 10, 100 and 1000 pmol l-1 for 48 hours |
|
Applications |
The addition of acylated and desacyl ghrelin during adipocyte differentiation induced a significant increase in PPARG and SREBF1 transcript levels. |
|
References: [1]: RodrÍguez A, GÓmez-Ambrosi J, CatalÁn V, et al. Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes[J]. International journal of obesity, 2009, 33(5): 541-552. |
|
| Cas No. | 258279-04-8 | SDF | |
| 别名 | 来诺瑞林 | ||
| 分子式 | C149H249N47O42 | 分子量 | 3370.9 |
| 溶解度 | Soluble in Water | 储存条件 | Desiccate at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 0.2967 mL | 1.4833 mL | 2.9666 mL |
| 5 mM | 0.0593 mL | 0.2967 mL | 0.5933 mL |
| 10 mM | 0.0297 mL | 0.1483 mL | 0.2967 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
